Quarterly report pursuant to Section 13 or 15(d)

Avinza Co-Promotion (Co-Promote Termination Liability) (Details)

v2.4.0.8
Avinza Co-Promotion (Co-Promote Termination Liability) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Summary of co-promote termination liability  
Net present value of payments based on estimated future net Avinza product sales $ 11,746
Assumed payments made by Pfizer or assignee (1,002)
Fair value adjustments (10,221)
Total co-promote termination liability $ 523